The Netter Collection of Medical Illustrations: Nervous System, Volume 7, Part I - Brain
Part I - Anatomy and Physiology
2nd Edition
Published on 11. March 2013
Book
Hardback
396 pages
978-1-4160-6387-2 (ISBN)
Description
Brain, Part 1 of The Netter Collection of Medical Illustrations: Nervous System, 2nd Edition, provides a highly visual guide to this complex organ, from basic neurodevelopment, neuroanatomy, neurophysiology, and cognition to classic disorders including to epilepsy, hypothalamus/pituitary with disorders of consciousness and sleep, movement disorders, cerebellum, stroke, multiple sclerosis, neurologic infections, neuro-oncology, headaches, and brain trauma. This spectacularly illustrated volume in the masterwork known as the (CIBA) Netter "Green Books" has been expanded and revised by Drs. H. Royden Jones, Jr., Ted M. Burns, Michael J. Aminoff, and Scott L. Pomeroy to mirror the many exciting advances in medicine and imaging - offering unparalleled insights into the broad clinical spectrum of brain disorders.
Get complete, integrated visual guidance on the brain with thorough, richly illustrated coverage.
Quickly understand complex topics thanks to a concise text-atlas format that provides a context bridge between primary and specialized medicine.
Clearly visualize how core concepts of anatomy, physiology, and other basic sciences correlate across disciplines.
Benefit from matchless Netter illustrations that offer precision, clarity, detail and realism as they provide a visual approach to the clinical presentation and care of the patient.
Gain a rich clinical view of all aspects of the brain in one comprehensive volume, conveyed through beautiful illustrations as well as up-to-date radiologic images.
Clearly see the connection between basic science and clinical practice with an integrated overview of normal structure and function as it relates to pathologic conditions.
Grasp current clinical concepts regarding development, pediatrics, and adult medicine captured in classic Netter illustrations, as well as new illustrations created specifically for this volume by artist-physician Carlos Machado, MD, and others working in the Netter style.
Get complete, integrated visual guidance on the brain with thorough, richly illustrated coverage.
Quickly understand complex topics thanks to a concise text-atlas format that provides a context bridge between primary and specialized medicine.
Clearly visualize how core concepts of anatomy, physiology, and other basic sciences correlate across disciplines.
Benefit from matchless Netter illustrations that offer precision, clarity, detail and realism as they provide a visual approach to the clinical presentation and care of the patient.
Gain a rich clinical view of all aspects of the brain in one comprehensive volume, conveyed through beautiful illustrations as well as up-to-date radiologic images.
Clearly see the connection between basic science and clinical practice with an integrated overview of normal structure and function as it relates to pathologic conditions.
Grasp current clinical concepts regarding development, pediatrics, and adult medicine captured in classic Netter illustrations, as well as new illustrations created specifically for this volume by artist-physician Carlos Machado, MD, and others working in the Netter style.
Reviews / Votes
"This book is masterful in many respects, but mostly in its ability to present information in a way that makes learning enjoyable. It does not go into micro detail on all of the nervous system diseases, but serves as a good review. Taken together, the two volumes would be a good addition to the bookshelf of any neurologist, healthcare professional, or medical student."-Andrea Harriott, MD, PhD(Mayo Clinic Florida) Doody Review: 86/100More details
Series
Edition
2nd edition
Language
English
Place of publication
London
United Kingdom
Publishing group
Elsevier Health Sciences
Target group
Professional and scholarly
Illustrations
332 illustrations (332 in full color); Illustrations
Weight
1540 gr
ISBN-13
978-1-4160-6387-2 (9781416063872)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
Michael J. Aminoff | Scott Pomeroy | Kerry H. Levin
The Netter Collection of Medical Illustrations: Nervous System, Volume 7, Part I - Brain
Book
05/2024
3rd Edition
Elsevier
€101.50
Shipment within 10-15 days
Additional editions
H. Royden Jones Jr. | Ted Burns MD | DSc Aminoff MD
The Netter Collection of Medical Illustrations: Nervous System, Volume 7, Part 1 - Brain
The Netter Collection of Medical Illustrations: Nervous System, Volume 7, Part 1 - Brain
E-Book
06/2013
2nd Edition
Saunders
€64.99
Available for download
Previous edition
Frank H. Netter
The Netter Collection of Medical Illustrations: Anatomy and Physiology pt. 1
Nervous System
Book
01/1984
Icon Learning Systems
€100.46
Article exhausted; check for reprint
Persons
Dr. H. Royden Jones was Chair of the Department of Neurology at Lahey Hospital and Medical Center, Burlington, Massachusetts; Director of the Electromyography Laboratory at Boston Children's Hospital; and Clinical Professor of Neurology at Harvard Medical School. Dr. Jones completed residencies in Internal Medicine and Neurology and a fellowship in neurological physiology at the Mayo Clinic. He served over 3 years in the United States Army as Chief of Neurology at 5th General Hospital, Bad Cannstatt, Germany. Dr. Jones was Board certified in neurology, clinical neurophysiology, and neuromuscular medicine. Upon completion of his training he joined the Lahey Clinic in 1972. In 1977 he also joined the neurology department at Boston Children's Hospital, founding the electromyography laboratory in 1979. Pediatric EMG became his major clinical research interest. Dr. Jones was co-editor of three major textbooks on childhood clinical neurophysiology and neuromuscular disorders. He was a co-founder of the biennial International Paediatric EMG Conference based at Great Ormond Street Children's Hospital, London, England. Recognized as one of the top neurologists in the U.S., Dr. Jones was an author and editor of several Netter publications including two editions of Netter's Neurology, The Netter Collection of Medical Illustrations: Nervous System, Volume 7, Part I (Brain) and Part II (Spinal Cord and Peripheral Motor and Sensory Systems), 2nd Editions (volumes in the Netter Green Book Collection). Dr. Jones authored and edited several other Netter publications and contributed over 200 peer-reviewed papers and book chapters. Dr. Jones served 8 years as a director of the American Board of Psychiatry and Neurology, becoming Chair of its Neurology Council in 2004. In 2007 he received the Distinguished Physician Award from the American Association of Neuromuscular and Electrodiagnostic Medicine. Lahey Clinic's Medical Staff Association recognized Dr. Jones in 2010 with its highest honor-the Frank Lahey Award for "commitment to the values of Dr. Frank Lahey: respect, teamwork, excellence, commitment to personal best.? Dr. Jones was named Outstanding Teacher in Pediatric Neurology 2012 - 2013 by the Department of Neurology, Boston Children's Hospital, Harvard Medical School. He also received an award in recognition of his many years of dedicated teaching at Tufts University School of Medicine. Dr. Michael J. Aminoff, Distinguished Professor Emeritus in neurology at the University of California San Francisco, is an internationally recognized neurologist, clinical investigator, and author. His published contributions led to the award of a Doctor of Science degree by the University of London in 2000. He is one of the two editors-in-chief of the four-volume Encyclopedia of the Neurological Sciences (2003; 2014) as well as one of the series editors of the multivolume Handbook of Clinical Neurology. He was editor-in-chief of the journal Muscle & Nerve from 1998 to 2007 and has served on numerous other editorial boards. He was a director of the American Board of Psychiatry and Neurology for eight years and served as board chair in 2011. In 2006, he received the Lifetime Achievement Award from the American Association of Neuromuscular & Electrodiagnostic Medicine and, in 2007, the A.B. Baker Award for Lifetime Achievement in Neurological Education from the American Academy of Neurology. In 2019 he received the Robert S. Schwab Award for outstanding contributions to research in peripheral clinical neurophysiology from the American Clinical Neurophysiology Society. Scott L. Pomeroy is an internationally known expert on the biological origins, treatment and long-term outcomes of childhood brain tumors. He has served as the Chair of the Department of Neurology and Neurologist-in-Chief of Boston Children's Hospital since 2005. Dr. Pomeroy graduated summa cum laude and Phi Beta Kappa from Miami University in 1975 and in 1982 was the first graduate of the M.D., Ph.D. program of the University of Cincinnati. He trained in pediatrics at Boston Children's Hospital/Harvard Medical School and in child neurology at St. Louis Children's Hospital/Washington University of St. Louis. In 1989, he won the Child Neurology Society Young Investigator Award for work done as a postdoctoral fellow of Dale Purves. The Pomeroy lab focuses on understanding the molecular and cellular basis of medulloblastomas and other embryonal brain tumors. Dr. Pomeroy has served as an ad hoc and chartered member of many NIH study sections, as co-Editor of Neurology in Clinical Practice and Associate Editor of Annals of Neurology, as President of the Child Neurology Foundation and as a member of the Dana Alliance for Brain Initiatives. He has received numerous awards including the Sidney Carter Award of the American Academy of Neurology, the Daniel Drake Medal of the University of Cincinnati, the inaugural Compassionate Caregiver Award of the Kenneth Schwartz Center, and the Bernard Sachs Award of the Child Neurology Society. In 2017, he was elected a member of the U.S. National Academy of Medicine.
Author
Children's Hospital, Boston, MA, USA
Professor of Neurology, University of Virginia, Charlottesville, Virginia
Distinguished Professor Emeritus in Neurology; University of California San Francisco, USA
Bronson Crothers Professor, Department of Neurology, Harvard Medical School; Consultant, Pediatric Oncology, Dana-Farber Cancer Institute; Neurologist-in-Chief, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA
Content
SECTION 1-NORMAL AND ABNORMAL
DEVELOPMENT
1-1 Embryo at 18 Days, 2
1-2 Embryo at 20 to 24 Days, 3
1-3 Central Nervous System at 28 Days, 4
1-4 Central Nervous System at 36 Days, 5
1-5 Defective Neural Tube Formation, 6
1-6 Defective Neural Tube Formation
(Continued), 7
1-7 Spinal Dysraphism, 8
1-8 Spinal Dysraphism (Continued), 9
1-9 Fetal Brain Growth in the First
Trimester, 10
1-10 Craniosynostosis, 11
1-11 Extracranial Hemorrhage and Skull
Fractures in the Newborn, 12
1-12 Intracranial Hemorrhage in the
Newborn, 13
1-13 The External Development of the Brain
in the Second and Third Trimesters, 14
1-14 Mature Brain Ventricles, 15
1-15 Hydrocephalus, 16
1-16 Surgical Treatment of Hydrocephalus, 17
1-17 Cerebral Palsy, 18
1-18 Establishing Cellular Diversity in the
Embryonic Brain and Spinal Cord, 20
1-19 Generation of Neuronal Diversity in the
Spinal Cord and Hindbrain, 22
1-20 Circuit Formation in the Spinal Cord, 23
1-21 Sheath and Satellite Cell Formation, 24
1-22 Development of Myelination and Axon
Ensheathment, 25
1-23 Brachial Plexus and/or Cervical Nerve
Root Injuries at Birth, 26
1-24 Morphogenesis and Regional
Differentiation of the Forebrain, 27
1-25 Neurogenesis and Cell Migration in the
Developing Neocortex, 28
1-26 Neuronal Proliferation and Migration
Disorders, 29
1-27 Developmental Dyslexia, 30
1-28 Autism Spectrum Disorders, 31
1-29 Rett Syndrome, 32
SECTION 2-CEREBRAL CORTEX AND
NEUROCOGNITIVE DISORDERS
2-1 Superolateral Surface of Brain, 34
2-2 Medial Surface of Brain, 35
2-3 Inferior Surface of Brain, 36
2-4 Cerebral Cortex: Function and
Association Pathways, 37
2-5 Major Cortical Association Bundles, 38
2-6 Corticocortical and Subcorticocortical
Projection Circuits, 39
2-7 Corpus Callosum, 40
2-8 Rhinencephalon and Limbic System, 41
2-9 Hippocampus, 42
2-10 Fornix, 43
2-11 Amygdala, 44
2-12 Forebrain Regions Associated with
Hypothalamus, 45
2-13 Thalamocortical Radiations, 46
2-14 Neuronal Structure and Synapses, 47
2-15 Chemical Synaptic Transmission, 48
2-16 Summation of Excitation and
Inhibition, 49
2-17 Types of Neurons in Cerebral Cortex, 50
2-18 Astrocytes, 51
2-19 Testing for Defects of Higher Cortical
Function, 52
2-20 Memory Circuits, 53
2-21 Amnesia, 54
2-22 Dominant Hemisphere Language
Dysfunction, 55
2-23 Nondominant Hemisphere Higher Cortical
Dysfunction, 56
2-24 Alzheimer Disease: Pathology, 57
2-25 Alzheimer Disease: Distribution of
Pathology, 58
2-26 Alzheimer Disease: Clinical
Manifestations, Progressive Phases, 59
2-27 Frontotemporal Dementia, 60
2-28 Dementia with Lewy Bodies, 61
2-29 Vascular Dementia, 62
2-30 Treatable Dementias, 63
2-31 Normal-Pressure Hydrocephalus, 64
SECTION 3-EPILEPSY
3-1 Electroencephalography, 66
3-2 Focal (Partial) Seizures, 67
3-3 Generalized Tonic-Clonic Seizures, 68
3-4 Absence Seizures, 69
3-5 Epileptic Syndromes, 70
3-6 Neonatal Seizures, 71
3-7 Status Epilepticus, 72
3-8 Causes of Seizures, 73
3-9 Neurobiology of Epilepsy, 74
3-10 Neurobiology of Epilepsy (Continued), 75
3-11 Neurobiology of Epilepsy (Continued), 76
3-12 Treatment of Epilepsy: Preoperative
Evaluation, 77
3-13 Treatment of Epilepsy: Resective
Surgery, 78
SECTION 4-PSYCHIATRY
4-1 Limbic System, 80
4-2 Major Depressive Disorder, 81
4-3 Postpartum Depression, 82
4-4 Bipolar Disorder, 83
4-5 Generalized Anxiety Disorder, 84
4-6 Social Anxiety disorder, 85
4-7 Panic Disorder, 86
4-8 Posttraumatic Stress Disorder, 87
4-9 Obsessive-Compulsive Disorder, 88
4-10 Somatization, 89
4-11 Conversion Disorder, 90
4-12 Schizophrenia, 91
4-13 Alcohol Use Disorders, 92
4-14 Treatment for Alcohol Use Disorders, 93
4-15 Alcohol Withdrawal, 94
4-16 Opioid Use Disorders, 95
4-17 Opioid Withdrawal, 96
4-18 Borderline Personality Disorder, 97
4-19 Antisocial Personality Disorder, 98
4-20 Intimate Partner Abuse, 99
4-21 Elder Abuse, 100
4-22 Delirium and Acute Personality
Changes, 101
4-23 Delirium and Acute Personality Changes
(Continued), 102
4-24 Insomnia, 103
4-25 Pediatrics: Depressive Disorders, 104
4-26 Pediatrics: Anxiety Disorders, 105
4-27 Pediatrics: Disruptive Behavior
Disorders, 106
4-28 Pediatrics: Attention-Deficit/Hyperactivity
Disorder, 107
4-29 Pediatrics: Eating Disorders, 108
4-30 Child Abuse: Fractures in Abused
Children, 109
4-31 Child Abuse: Staging of Injuries and
Injury Patterns, 110
SECTION 5-HYPOTHALAMUS, PITUITARY,
SLEEP, AND THALAMUS
5-1 Anatomic Relationships of the
Hypothalamus, 112
5-2 Development and Developmental
Disorders of the Hypothalamus, 113
5-3 Blood Supply of the Hypothalamus and
Pituitary Gland, 114
5-4 General Topography of the
Hypothalamus, 115
5-5 Overview of Hypothalamic Nuclei, 116
5-6 Hypothalamic Control of the Pituitary
Gland, 117
5-7 Hypothalamic Control of the Autonomic
Nervous System, 118
5-8 Olfactory Inputs to the
Hypothalamus, 119
5-9 Visual Inputs to the Hypothalamus, 120
5-10 Somatosensory Inputs to the
Hypothalamus, 121
5-11 Taste and Other Visceral Sensory Inputs
to the Hypothalamus, 122
5-12 Limbic and Cortical Inputs to the
Hypothalamus, 123
5-13 Overview of Hypothalamic Function and
Dysfunction, 124
5-14 Regulation of Water Balance, 125
5-15 Temperature Regulation, 126
5-16 Fever: Cytokines and Prostaglandins
Cause the Sickness Response, 127
5-17 Fever: Hypothalamic Responses During
Inflammation Modulate Immune
Response, 128
5-18 Regulation of Food Intake, Body Weight,
and Metabolism, 129
5-19 Stress Response, 130
5-20 Hypothalamic Regulation of
Cardiovascular Function, 131
5-21 Hypothalamic Regulation of Sleep, 132
5-22 Narcolepsy: A Hypothalamic Sleep
Disorder, 133
5-23 Sleep-Disordered Breathing, 134
5-24 Parasomnias, 135
5-25 Divisions of the Pituitary Gland
and Its Relationships to the
Hypothalamus, 136
5-26 Posterior Pituitary Gland, 137
5-27 Anatomic Relationships of the Pituitary
Gland, 138
5-28 Effects of Pituitary Mass Lesions on the
Visual Apparatus, 139
5-29 Anterior Pituitary Hormone
Deficiencies, 140
5-30 Severe Anterior Pituitary Hormone
Deficiencies (Panhypopituitarism), 141
5-31 Postpartum Pituitary Infarction (Sheehan
Syndrome), 142
5-32 Pituitary Apoplexy, 143
5-33 Thalamic Anatomy and Pathology, 144
5-34 Thalamic Anatomy and Pathology
(Continued), 145
SECTION 6-DISORDERS OF
CONSCIOUSNESS (COMA)
6-1 Coma, 148
6-2 Disorders of Consciousness, 149
6-3 Full Outline of Unresponsiveness Score
(FOUR), 150
6-4 Prognosis in Coma Related to Severe
Head Injuries, 151
6-5 Differential Diagnosis of Coma, 152
6-6 Hypoxic-Ischemic Brain Damage, 153
6-7 Vegetative State and Minimally Conscious
State, 154
6-8 Brain Death, 155
6-9 Ventilatory Patterns and Apnea Test, 156
SECTION 7-BASAL GANGLIA AND
MOVEMENT DISORDERS
7-1 Basal Nuclei (Ganglia), 158
7-2 Basal Ganglia and Related Structures 159
7-3 Schematic and Cross Section of Basal
Ganglia, 160
7-4 Parkinsonism: Early Manifestations, 161
7-5 Parkinsonism: Successive Clinical
Stages, 162
7-6 Neuropathology of Parkinson
Disease, 163
7-7 Progressive Supranuclear Palsy, 164
7-8 Corticobasal Degeneration, 165
7-9 Parkinsonism: Hypothesized Role of
Dopamine, 166
7-10 Surgical Management of Movement
Disorders, 167
7-11 Hyperkinetic Movement Disorder:
Idiopathic Torsion Dystonia, 168
7-12 Hyperkinetic Movement Disorder:
Cervical Dystonia, 169
7-13 Chorea/Ballism, 170
7-14 Tremor, 171
7-15 Tics and Tourette Syndrome, 172
7-16 Myoclonus, 173
7-17 Wilson Disease, 174
7-18 Psychogenic Movement Disorders, 175
7-19 Cerebral Palsy, 176
SECTION 8-CEREBELLUM AND ATAXIA
8-1 Cerebellum and the Fourth Ventricle, 178
8-2 Cerebellum Gross Anatomy, 179
8-3 Cerebellar Peduncles, 180
8-4 Cerebellar Cortex and Nuclei, 181
8-5 Cerebellar Cortex and Nuclei
(Continued), 182
8-6 Cerebellar Cortical and Corticonuclear
Circuitry, 183
8-7 Cerebellar Cortical and Corticonuclear
Circuitry (Continued), 184
8-8 Cerebellum Subdivisions and Afferent
Pathways, 185
8-9 Cerebellum Subdivisions and Afferent
Pathways (Continued), 186
8-10 Cerebellar Efferent Pathways, 187
8-11 Cerebellovestibular Pathways, 189
8-12 Cerebellum Modular Organization, 190
8-13 Cerebrocerebellar Connections, 191
8-14 Cerebellar Motor Examination, 192
8-15 Cerebellar Cognitive Affective
Syndrome, 193
8-16 Cerebellar Disorders Differential
Diagnosis, 194
8-17 Gait Disorders-Differential
Diagnosis, 195
8-18 Gait Disorders-Differential Diagnosis
(Continued), 196
8-19 Friedreich Ataxia, 197
SECTION 9-CEREBROVASCULAR
CIRCULATION AND STROKE
OVERVIEW AND APPROACH TO STROKE PATIENT
9-1 Arteries to Brain and Meninges, 200
9-2 Territories of the Cerebral Arteries, 201
9-3 Arteries of Brain: Lateral and Medial
Views, 202
9-4 Arteries Of Brain: Frontal View and
Section, 203
9-5 Stroke Subtypes, 204
9-6 Temporal Profile of Transient Ischemic
Attack (TIA) and Completed Infarction
(CI), 205
9-7 Clinical Evaluation and Therapeutic
Options in Stroke, 206
9-8 Clinical Evaluation and Therapeutic
Options in Stroke (Continued), 207
9-9 Uncommon Etiologic Mechanisms in
Stroke, 208
ANTERIOR CIRCULATION ISCHEMIA
9-10 Common Sites of Cerebrovascular
Occlusive Disease, 209
9-11 Other Etiologies of Carotid Artery
Disease, 210
9-12 Clinical Manifestations of Carotid Artery
Disease, 211
9-13 Occlusion of Middle and Anterior
Cerebral Arteries, 212
9-14 Diagnosis of Internal Carotid
Disease, 213
9-15 Diagnosis of Carotid Artery Disease, 214
9-16 Carotid Endarterectomy, 215
9-17 Endovascular ICA Angioplasty and
Stenting Using A Protective Device, 216
VERTEBRAL BASILAR SYSTEM DISORDERS
9-18 Arterial Distribution to the Brain: Basal
View, 217
9-19 Arteries of Posterior Cranial Fossa, 218
9-20 Clinical Manifestations of Vertebrobasilar
Territory Ischemia, 219
9-21 Intracranial Occlusion of Vertebral
Artery, 220
9-22 Occlusion of Basilar Artery and
Branches, 221
9-23 Occlusion of "Top of Basilar? and
Posterior Cerebral Arteries, 222
BRAIN EMBOLI
9-24 Cardiac Sources of Brain Emboli, 223
9-25 Uncommon Cardiac Mechanisms In
Stroke, 224
LACUNAR STROKE
9-26 Lacunar Infarction, 225
9-27 Risk Factors for Cardiovascular
Disease, 226
OTHER
9-28 Hypertensive Encephalopathy, 227
9-29 Hypoxia, 228
COAGULOPATHIES
9-30 Role of Platelets in Arterial
Thrombosis, 229
9-31 Inherited Thrombophilias, 230
9-32 Antiphospholipid Antibody
Syndrome, 231
VENOUS SINUS THROMBOSIS
9-33 Meninges and Superficial Cerebral
Veins, 232
9-34 Intracranial Venous Sinuses, 233
9-35 Diagnosis of Venous Sinus
Thrombosis, 234
INTRACEREBRAL HEMORRHAGE
9-36 Pathogenesis and Types, 235
9-37 Clinical Manifestations of Intracranial
Hemorrhage Related to Site, 236
9-38 Vascular Malformations, 237
SUBARACHNOID HEMORRHAGE AND
INTRACRANIAL ANEURYSMS
9-39 Distribution and Clinical Manifestations
of Congenital Aneurysm Rupture, 238
9-40 Giant Congenital Aneurysms, 239
9-41 Ophthalmologic Manifestations of
Cerebral Aneurysms, 240
9-42 Approach to Internal Carotid
Aneurysms, 241
9-43 Interventional Radiologic Repair of Berry
Aneurysms, 242
PEDIATRICS
9-44 Pediatric Cerebrovascular Disease, 243
REHABILITATION
9-45 Positioning in Bed and Passive
Range-of-Motion Exercises After
Stroke, 244
9-46 Aphasia Rehabilitation, 245
9-47 Other Rehabilitative Issues: Dysphagia/
Gait Training/Locked-in Syndrome, 246
SECTION 10-MULTIPLE SCLEROSIS AND
OTHER CENTRAL NERVOUS SYSTEM
AUTOIMMUNE DISORDERS
MULTIPLE SCLEROSIS
10-1 Overview, 248
10-2 Clinical Manifestations, 249
10-3 Diagnosis, 250
10-4 Diagnosis: Spinal Cord MRI in Multiple
Sclerosis, 251
10-5 Diagnosis: Visual Evoked Response and
Spinal Fluid Analysis, 252
10-6 MS Pathophysiology, 253
10-7 MS Pathophysiology (Continued), 254
10-8 MS Relapses, 256
10-9 MS Relapses (Continued), 257
10-10 MS Relapses (Continued), 258
10-11 MS Relapses: Consequences, 259
10-12 Enigma of Progressive MS, 260
10-13 MS Pathology, 261
10-14 MS Treatment, 262
NEUROIMMUNOLOGIC SYNDROMES
10-15 Neuromyelitis Optica, Acute
Disseminated Encephalomyelitis, and
Acute Hemorrhagic Leukoencephalitis
-Radiologic Findings, 264
10-16 Neuromyelitis Optica, Acute
Disseminated Encephalomyelitis, and
Acute Hemorrhagic Leukoencephalitis-
Histopathologic Findings, 265
10-17 Other Neuroimmunologic Syndromes:
an Overlap Between Primary and
Paraneoplastic Processes, 266
10-18 Stiff-Man Syndrome, 267
10-19 Paraneoplastic Immune-Mediated
Disorders, 268
10-20 Paraneoplastic Immune-Mediated
Disorders (Continued), 269
10-21 Neuroimmunology: Paraneoplastic and
Other Autoimmune Syndromes-Central
Nervous System, 270
10-22 Neuroimmunology: Paraneoplastic and
Other Autoimmune Syndromes-
Peripheral Motor Sensory Unit, 271
SECTION 11-INFECTIONS OF
THE NERVOUS SYSTEM
11-1 Bacterial Meningitis, 274
11-2 Bacterial Meningitis (Continued), 275
11-3 Brain Abscess, 276
11-4 Parameningeal Infections, 277
11-5 Infections in the Immunocompromised
Host: Progressive Multifocal
Leukoencephalopathy and
Nocardiosis, 278
11-6 Infections in the Immunocompromised
Host: Listeriosis and Toxoplasmosis, 279
11-7 Neurocysticercosis, 280
11-8 Spirochetal Infections: Neurosyphilis, 281
11-9 Spirochetal Infections: Lyme
Disease, 282
11-10 Tuberculosis of Brain and Spine, 283
11-11 Tetanus, 284
11-12 Aseptic Meningitis, 285
11-13 Primary HIV Infection of the Nervous
System, 286
11-14 HIV Life Cycle and Antiretroviral
Medications, 287
11-15 Poliomyelitis, 288
11-16 Herpes Zoster, 289
11-17 Herpes Simplex Virus Encephalitis and
Rabies, 290
11-18 Cerebral Malaria and African
Trypanosomiasis, 291
11-19 Trichinosis (Trichinellosis), 292
11-20 Cryptococcal Meningitis, 293
11-21 Creutzfeldt-Jakob Disease, 294
11-22 Neurosarcoidosis, 295
SECTION 12-NEURO-ONCOLOGY
12-1 Clinical Presentations of Brain
Tumors, 298
12-2 Gliomas, 299
12-3 Glioblastoma, 300
12-4 Pediatric Brain Tumors, 301
12-5 Pediatric Brain Tumors (Continued), 302
12-6 Metastatic Tumors to Brain, 303
12-7 Meningiomas, 304
12-8 Meningiomas (Continued), 305
12-9 Pituitary Tumors, 306
12-10 Clinically Nonfunctioning Pituitary
Tumor, 307
12-11 Craniopharyngioma, 308
12-12 Tumors of Pineal Region, 309
12-13 Vestibular Schwannomas, 310
12-14 Removal of Vestibular Schwannoma, 311
12-15 Intraventricular Tumors, 312
12-16 Chordomas, 313
12-17 Differential Diagnosis of CNS
Tumors, 314
12-18 Treatment Modalities, 315
SECTION 13-HEADACHE
13-1 Overview of Headaches, 318
13-2 Migraine Pathophysiology, 319
13-3 Migraine Presentation, 320
13-4 Migraine Aura, 321
13-5 Migraine Management, 322
13-6 Trigeminal Autonomic Cephalagias:
Cluster Headache, 323
13-7 Trigeminal Autonomic Cephalagias:
Paroxysmal Hemicrania (PH), 324
13-8 Tension-Type Headache and Other
Benign Episodic and Chronic
Headaches, 325
13-9 Pediatric Headache, 326
13-10 Cranial Neuralgias-Trigeminal
Neuralgia, 327
13-11 Other Cranial Neuralgias, 328
13-12 Idiopathic Intracranial Hypertension (IIH),
Pseudotumor Cerebri, 329
13-13 Intracranial Hypotension/ Low
Cerebrospinal Fluid Pressure
Headache, 330
13-14 Giant Cell Arteritis, 331
13-15 Contiguous Structure Headaches, 332
13-16 Thunderclap Headache and Other
Headaches Presenting in the Emergency
Department, 333
13-17 Headaches Presenting in the Emergency
Department (Continued), 334
13-18 Headaches Presenting in the Emergency
Department (Continued), 335
13-19 Headaches Presenting in the Emergency
Department (Continued), 336
SECTION 14-HEAD TRAUMA
14-1 Skull: Anterior View, 338
14-2 Skull: Lateral View, 339
14-3 Skull: Midsagittal Section, 340
14-4 Calvaria, 341
14-5 External Aspect of Skull Base, 342
14-6 Internal Aspects of Base of Skull:
Bones, 343
14-7 Internal Aspects of Base of Skull:
Orifices, 344
14-8 Skull Injuries, 345
14-9 Concussion, 346
14-10 Acute Epidural Hematoma, 347
14-11 Acute Subdural Hematoma, 348
14-12 CT Scans and MR Images of Intracranial
Hematomas, 349
14-13 Vascular Injury, 350
14-14 Initial Assessment and Management of
Head Injury, 351
14-15 Glasgow Coma Score, 352
14-16 Neurocritical Care and Management
after Traumatic Brain Injury: Devices
for Monitoring Intracranial
Pressure, 353
14-17 Neurocritical Care and Management:
Decompressive Craniectomy, 354
DEVELOPMENT
1-1 Embryo at 18 Days, 2
1-2 Embryo at 20 to 24 Days, 3
1-3 Central Nervous System at 28 Days, 4
1-4 Central Nervous System at 36 Days, 5
1-5 Defective Neural Tube Formation, 6
1-6 Defective Neural Tube Formation
(Continued), 7
1-7 Spinal Dysraphism, 8
1-8 Spinal Dysraphism (Continued), 9
1-9 Fetal Brain Growth in the First
Trimester, 10
1-10 Craniosynostosis, 11
1-11 Extracranial Hemorrhage and Skull
Fractures in the Newborn, 12
1-12 Intracranial Hemorrhage in the
Newborn, 13
1-13 The External Development of the Brain
in the Second and Third Trimesters, 14
1-14 Mature Brain Ventricles, 15
1-15 Hydrocephalus, 16
1-16 Surgical Treatment of Hydrocephalus, 17
1-17 Cerebral Palsy, 18
1-18 Establishing Cellular Diversity in the
Embryonic Brain and Spinal Cord, 20
1-19 Generation of Neuronal Diversity in the
Spinal Cord and Hindbrain, 22
1-20 Circuit Formation in the Spinal Cord, 23
1-21 Sheath and Satellite Cell Formation, 24
1-22 Development of Myelination and Axon
Ensheathment, 25
1-23 Brachial Plexus and/or Cervical Nerve
Root Injuries at Birth, 26
1-24 Morphogenesis and Regional
Differentiation of the Forebrain, 27
1-25 Neurogenesis and Cell Migration in the
Developing Neocortex, 28
1-26 Neuronal Proliferation and Migration
Disorders, 29
1-27 Developmental Dyslexia, 30
1-28 Autism Spectrum Disorders, 31
1-29 Rett Syndrome, 32
SECTION 2-CEREBRAL CORTEX AND
NEUROCOGNITIVE DISORDERS
2-1 Superolateral Surface of Brain, 34
2-2 Medial Surface of Brain, 35
2-3 Inferior Surface of Brain, 36
2-4 Cerebral Cortex: Function and
Association Pathways, 37
2-5 Major Cortical Association Bundles, 38
2-6 Corticocortical and Subcorticocortical
Projection Circuits, 39
2-7 Corpus Callosum, 40
2-8 Rhinencephalon and Limbic System, 41
2-9 Hippocampus, 42
2-10 Fornix, 43
2-11 Amygdala, 44
2-12 Forebrain Regions Associated with
Hypothalamus, 45
2-13 Thalamocortical Radiations, 46
2-14 Neuronal Structure and Synapses, 47
2-15 Chemical Synaptic Transmission, 48
2-16 Summation of Excitation and
Inhibition, 49
2-17 Types of Neurons in Cerebral Cortex, 50
2-18 Astrocytes, 51
2-19 Testing for Defects of Higher Cortical
Function, 52
2-20 Memory Circuits, 53
2-21 Amnesia, 54
2-22 Dominant Hemisphere Language
Dysfunction, 55
2-23 Nondominant Hemisphere Higher Cortical
Dysfunction, 56
2-24 Alzheimer Disease: Pathology, 57
2-25 Alzheimer Disease: Distribution of
Pathology, 58
2-26 Alzheimer Disease: Clinical
Manifestations, Progressive Phases, 59
2-27 Frontotemporal Dementia, 60
2-28 Dementia with Lewy Bodies, 61
2-29 Vascular Dementia, 62
2-30 Treatable Dementias, 63
2-31 Normal-Pressure Hydrocephalus, 64
SECTION 3-EPILEPSY
3-1 Electroencephalography, 66
3-2 Focal (Partial) Seizures, 67
3-3 Generalized Tonic-Clonic Seizures, 68
3-4 Absence Seizures, 69
3-5 Epileptic Syndromes, 70
3-6 Neonatal Seizures, 71
3-7 Status Epilepticus, 72
3-8 Causes of Seizures, 73
3-9 Neurobiology of Epilepsy, 74
3-10 Neurobiology of Epilepsy (Continued), 75
3-11 Neurobiology of Epilepsy (Continued), 76
3-12 Treatment of Epilepsy: Preoperative
Evaluation, 77
3-13 Treatment of Epilepsy: Resective
Surgery, 78
SECTION 4-PSYCHIATRY
4-1 Limbic System, 80
4-2 Major Depressive Disorder, 81
4-3 Postpartum Depression, 82
4-4 Bipolar Disorder, 83
4-5 Generalized Anxiety Disorder, 84
4-6 Social Anxiety disorder, 85
4-7 Panic Disorder, 86
4-8 Posttraumatic Stress Disorder, 87
4-9 Obsessive-Compulsive Disorder, 88
4-10 Somatization, 89
4-11 Conversion Disorder, 90
4-12 Schizophrenia, 91
4-13 Alcohol Use Disorders, 92
4-14 Treatment for Alcohol Use Disorders, 93
4-15 Alcohol Withdrawal, 94
4-16 Opioid Use Disorders, 95
4-17 Opioid Withdrawal, 96
4-18 Borderline Personality Disorder, 97
4-19 Antisocial Personality Disorder, 98
4-20 Intimate Partner Abuse, 99
4-21 Elder Abuse, 100
4-22 Delirium and Acute Personality
Changes, 101
4-23 Delirium and Acute Personality Changes
(Continued), 102
4-24 Insomnia, 103
4-25 Pediatrics: Depressive Disorders, 104
4-26 Pediatrics: Anxiety Disorders, 105
4-27 Pediatrics: Disruptive Behavior
Disorders, 106
4-28 Pediatrics: Attention-Deficit/Hyperactivity
Disorder, 107
4-29 Pediatrics: Eating Disorders, 108
4-30 Child Abuse: Fractures in Abused
Children, 109
4-31 Child Abuse: Staging of Injuries and
Injury Patterns, 110
SECTION 5-HYPOTHALAMUS, PITUITARY,
SLEEP, AND THALAMUS
5-1 Anatomic Relationships of the
Hypothalamus, 112
5-2 Development and Developmental
Disorders of the Hypothalamus, 113
5-3 Blood Supply of the Hypothalamus and
Pituitary Gland, 114
5-4 General Topography of the
Hypothalamus, 115
5-5 Overview of Hypothalamic Nuclei, 116
5-6 Hypothalamic Control of the Pituitary
Gland, 117
5-7 Hypothalamic Control of the Autonomic
Nervous System, 118
5-8 Olfactory Inputs to the
Hypothalamus, 119
5-9 Visual Inputs to the Hypothalamus, 120
5-10 Somatosensory Inputs to the
Hypothalamus, 121
5-11 Taste and Other Visceral Sensory Inputs
to the Hypothalamus, 122
5-12 Limbic and Cortical Inputs to the
Hypothalamus, 123
5-13 Overview of Hypothalamic Function and
Dysfunction, 124
5-14 Regulation of Water Balance, 125
5-15 Temperature Regulation, 126
5-16 Fever: Cytokines and Prostaglandins
Cause the Sickness Response, 127
5-17 Fever: Hypothalamic Responses During
Inflammation Modulate Immune
Response, 128
5-18 Regulation of Food Intake, Body Weight,
and Metabolism, 129
5-19 Stress Response, 130
5-20 Hypothalamic Regulation of
Cardiovascular Function, 131
5-21 Hypothalamic Regulation of Sleep, 132
5-22 Narcolepsy: A Hypothalamic Sleep
Disorder, 133
5-23 Sleep-Disordered Breathing, 134
5-24 Parasomnias, 135
5-25 Divisions of the Pituitary Gland
and Its Relationships to the
Hypothalamus, 136
5-26 Posterior Pituitary Gland, 137
5-27 Anatomic Relationships of the Pituitary
Gland, 138
5-28 Effects of Pituitary Mass Lesions on the
Visual Apparatus, 139
5-29 Anterior Pituitary Hormone
Deficiencies, 140
5-30 Severe Anterior Pituitary Hormone
Deficiencies (Panhypopituitarism), 141
5-31 Postpartum Pituitary Infarction (Sheehan
Syndrome), 142
5-32 Pituitary Apoplexy, 143
5-33 Thalamic Anatomy and Pathology, 144
5-34 Thalamic Anatomy and Pathology
(Continued), 145
SECTION 6-DISORDERS OF
CONSCIOUSNESS (COMA)
6-1 Coma, 148
6-2 Disorders of Consciousness, 149
6-3 Full Outline of Unresponsiveness Score
(FOUR), 150
6-4 Prognosis in Coma Related to Severe
Head Injuries, 151
6-5 Differential Diagnosis of Coma, 152
6-6 Hypoxic-Ischemic Brain Damage, 153
6-7 Vegetative State and Minimally Conscious
State, 154
6-8 Brain Death, 155
6-9 Ventilatory Patterns and Apnea Test, 156
SECTION 7-BASAL GANGLIA AND
MOVEMENT DISORDERS
7-1 Basal Nuclei (Ganglia), 158
7-2 Basal Ganglia and Related Structures 159
7-3 Schematic and Cross Section of Basal
Ganglia, 160
7-4 Parkinsonism: Early Manifestations, 161
7-5 Parkinsonism: Successive Clinical
Stages, 162
7-6 Neuropathology of Parkinson
Disease, 163
7-7 Progressive Supranuclear Palsy, 164
7-8 Corticobasal Degeneration, 165
7-9 Parkinsonism: Hypothesized Role of
Dopamine, 166
7-10 Surgical Management of Movement
Disorders, 167
7-11 Hyperkinetic Movement Disorder:
Idiopathic Torsion Dystonia, 168
7-12 Hyperkinetic Movement Disorder:
Cervical Dystonia, 169
7-13 Chorea/Ballism, 170
7-14 Tremor, 171
7-15 Tics and Tourette Syndrome, 172
7-16 Myoclonus, 173
7-17 Wilson Disease, 174
7-18 Psychogenic Movement Disorders, 175
7-19 Cerebral Palsy, 176
SECTION 8-CEREBELLUM AND ATAXIA
8-1 Cerebellum and the Fourth Ventricle, 178
8-2 Cerebellum Gross Anatomy, 179
8-3 Cerebellar Peduncles, 180
8-4 Cerebellar Cortex and Nuclei, 181
8-5 Cerebellar Cortex and Nuclei
(Continued), 182
8-6 Cerebellar Cortical and Corticonuclear
Circuitry, 183
8-7 Cerebellar Cortical and Corticonuclear
Circuitry (Continued), 184
8-8 Cerebellum Subdivisions and Afferent
Pathways, 185
8-9 Cerebellum Subdivisions and Afferent
Pathways (Continued), 186
8-10 Cerebellar Efferent Pathways, 187
8-11 Cerebellovestibular Pathways, 189
8-12 Cerebellum Modular Organization, 190
8-13 Cerebrocerebellar Connections, 191
8-14 Cerebellar Motor Examination, 192
8-15 Cerebellar Cognitive Affective
Syndrome, 193
8-16 Cerebellar Disorders Differential
Diagnosis, 194
8-17 Gait Disorders-Differential
Diagnosis, 195
8-18 Gait Disorders-Differential Diagnosis
(Continued), 196
8-19 Friedreich Ataxia, 197
SECTION 9-CEREBROVASCULAR
CIRCULATION AND STROKE
OVERVIEW AND APPROACH TO STROKE PATIENT
9-1 Arteries to Brain and Meninges, 200
9-2 Territories of the Cerebral Arteries, 201
9-3 Arteries of Brain: Lateral and Medial
Views, 202
9-4 Arteries Of Brain: Frontal View and
Section, 203
9-5 Stroke Subtypes, 204
9-6 Temporal Profile of Transient Ischemic
Attack (TIA) and Completed Infarction
(CI), 205
9-7 Clinical Evaluation and Therapeutic
Options in Stroke, 206
9-8 Clinical Evaluation and Therapeutic
Options in Stroke (Continued), 207
9-9 Uncommon Etiologic Mechanisms in
Stroke, 208
ANTERIOR CIRCULATION ISCHEMIA
9-10 Common Sites of Cerebrovascular
Occlusive Disease, 209
9-11 Other Etiologies of Carotid Artery
Disease, 210
9-12 Clinical Manifestations of Carotid Artery
Disease, 211
9-13 Occlusion of Middle and Anterior
Cerebral Arteries, 212
9-14 Diagnosis of Internal Carotid
Disease, 213
9-15 Diagnosis of Carotid Artery Disease, 214
9-16 Carotid Endarterectomy, 215
9-17 Endovascular ICA Angioplasty and
Stenting Using A Protective Device, 216
VERTEBRAL BASILAR SYSTEM DISORDERS
9-18 Arterial Distribution to the Brain: Basal
View, 217
9-19 Arteries of Posterior Cranial Fossa, 218
9-20 Clinical Manifestations of Vertebrobasilar
Territory Ischemia, 219
9-21 Intracranial Occlusion of Vertebral
Artery, 220
9-22 Occlusion of Basilar Artery and
Branches, 221
9-23 Occlusion of "Top of Basilar? and
Posterior Cerebral Arteries, 222
BRAIN EMBOLI
9-24 Cardiac Sources of Brain Emboli, 223
9-25 Uncommon Cardiac Mechanisms In
Stroke, 224
LACUNAR STROKE
9-26 Lacunar Infarction, 225
9-27 Risk Factors for Cardiovascular
Disease, 226
OTHER
9-28 Hypertensive Encephalopathy, 227
9-29 Hypoxia, 228
COAGULOPATHIES
9-30 Role of Platelets in Arterial
Thrombosis, 229
9-31 Inherited Thrombophilias, 230
9-32 Antiphospholipid Antibody
Syndrome, 231
VENOUS SINUS THROMBOSIS
9-33 Meninges and Superficial Cerebral
Veins, 232
9-34 Intracranial Venous Sinuses, 233
9-35 Diagnosis of Venous Sinus
Thrombosis, 234
INTRACEREBRAL HEMORRHAGE
9-36 Pathogenesis and Types, 235
9-37 Clinical Manifestations of Intracranial
Hemorrhage Related to Site, 236
9-38 Vascular Malformations, 237
SUBARACHNOID HEMORRHAGE AND
INTRACRANIAL ANEURYSMS
9-39 Distribution and Clinical Manifestations
of Congenital Aneurysm Rupture, 238
9-40 Giant Congenital Aneurysms, 239
9-41 Ophthalmologic Manifestations of
Cerebral Aneurysms, 240
9-42 Approach to Internal Carotid
Aneurysms, 241
9-43 Interventional Radiologic Repair of Berry
Aneurysms, 242
PEDIATRICS
9-44 Pediatric Cerebrovascular Disease, 243
REHABILITATION
9-45 Positioning in Bed and Passive
Range-of-Motion Exercises After
Stroke, 244
9-46 Aphasia Rehabilitation, 245
9-47 Other Rehabilitative Issues: Dysphagia/
Gait Training/Locked-in Syndrome, 246
SECTION 10-MULTIPLE SCLEROSIS AND
OTHER CENTRAL NERVOUS SYSTEM
AUTOIMMUNE DISORDERS
MULTIPLE SCLEROSIS
10-1 Overview, 248
10-2 Clinical Manifestations, 249
10-3 Diagnosis, 250
10-4 Diagnosis: Spinal Cord MRI in Multiple
Sclerosis, 251
10-5 Diagnosis: Visual Evoked Response and
Spinal Fluid Analysis, 252
10-6 MS Pathophysiology, 253
10-7 MS Pathophysiology (Continued), 254
10-8 MS Relapses, 256
10-9 MS Relapses (Continued), 257
10-10 MS Relapses (Continued), 258
10-11 MS Relapses: Consequences, 259
10-12 Enigma of Progressive MS, 260
10-13 MS Pathology, 261
10-14 MS Treatment, 262
NEUROIMMUNOLOGIC SYNDROMES
10-15 Neuromyelitis Optica, Acute
Disseminated Encephalomyelitis, and
Acute Hemorrhagic Leukoencephalitis
-Radiologic Findings, 264
10-16 Neuromyelitis Optica, Acute
Disseminated Encephalomyelitis, and
Acute Hemorrhagic Leukoencephalitis-
Histopathologic Findings, 265
10-17 Other Neuroimmunologic Syndromes:
an Overlap Between Primary and
Paraneoplastic Processes, 266
10-18 Stiff-Man Syndrome, 267
10-19 Paraneoplastic Immune-Mediated
Disorders, 268
10-20 Paraneoplastic Immune-Mediated
Disorders (Continued), 269
10-21 Neuroimmunology: Paraneoplastic and
Other Autoimmune Syndromes-Central
Nervous System, 270
10-22 Neuroimmunology: Paraneoplastic and
Other Autoimmune Syndromes-
Peripheral Motor Sensory Unit, 271
SECTION 11-INFECTIONS OF
THE NERVOUS SYSTEM
11-1 Bacterial Meningitis, 274
11-2 Bacterial Meningitis (Continued), 275
11-3 Brain Abscess, 276
11-4 Parameningeal Infections, 277
11-5 Infections in the Immunocompromised
Host: Progressive Multifocal
Leukoencephalopathy and
Nocardiosis, 278
11-6 Infections in the Immunocompromised
Host: Listeriosis and Toxoplasmosis, 279
11-7 Neurocysticercosis, 280
11-8 Spirochetal Infections: Neurosyphilis, 281
11-9 Spirochetal Infections: Lyme
Disease, 282
11-10 Tuberculosis of Brain and Spine, 283
11-11 Tetanus, 284
11-12 Aseptic Meningitis, 285
11-13 Primary HIV Infection of the Nervous
System, 286
11-14 HIV Life Cycle and Antiretroviral
Medications, 287
11-15 Poliomyelitis, 288
11-16 Herpes Zoster, 289
11-17 Herpes Simplex Virus Encephalitis and
Rabies, 290
11-18 Cerebral Malaria and African
Trypanosomiasis, 291
11-19 Trichinosis (Trichinellosis), 292
11-20 Cryptococcal Meningitis, 293
11-21 Creutzfeldt-Jakob Disease, 294
11-22 Neurosarcoidosis, 295
SECTION 12-NEURO-ONCOLOGY
12-1 Clinical Presentations of Brain
Tumors, 298
12-2 Gliomas, 299
12-3 Glioblastoma, 300
12-4 Pediatric Brain Tumors, 301
12-5 Pediatric Brain Tumors (Continued), 302
12-6 Metastatic Tumors to Brain, 303
12-7 Meningiomas, 304
12-8 Meningiomas (Continued), 305
12-9 Pituitary Tumors, 306
12-10 Clinically Nonfunctioning Pituitary
Tumor, 307
12-11 Craniopharyngioma, 308
12-12 Tumors of Pineal Region, 309
12-13 Vestibular Schwannomas, 310
12-14 Removal of Vestibular Schwannoma, 311
12-15 Intraventricular Tumors, 312
12-16 Chordomas, 313
12-17 Differential Diagnosis of CNS
Tumors, 314
12-18 Treatment Modalities, 315
SECTION 13-HEADACHE
13-1 Overview of Headaches, 318
13-2 Migraine Pathophysiology, 319
13-3 Migraine Presentation, 320
13-4 Migraine Aura, 321
13-5 Migraine Management, 322
13-6 Trigeminal Autonomic Cephalagias:
Cluster Headache, 323
13-7 Trigeminal Autonomic Cephalagias:
Paroxysmal Hemicrania (PH), 324
13-8 Tension-Type Headache and Other
Benign Episodic and Chronic
Headaches, 325
13-9 Pediatric Headache, 326
13-10 Cranial Neuralgias-Trigeminal
Neuralgia, 327
13-11 Other Cranial Neuralgias, 328
13-12 Idiopathic Intracranial Hypertension (IIH),
Pseudotumor Cerebri, 329
13-13 Intracranial Hypotension/ Low
Cerebrospinal Fluid Pressure
Headache, 330
13-14 Giant Cell Arteritis, 331
13-15 Contiguous Structure Headaches, 332
13-16 Thunderclap Headache and Other
Headaches Presenting in the Emergency
Department, 333
13-17 Headaches Presenting in the Emergency
Department (Continued), 334
13-18 Headaches Presenting in the Emergency
Department (Continued), 335
13-19 Headaches Presenting in the Emergency
Department (Continued), 336
SECTION 14-HEAD TRAUMA
14-1 Skull: Anterior View, 338
14-2 Skull: Lateral View, 339
14-3 Skull: Midsagittal Section, 340
14-4 Calvaria, 341
14-5 External Aspect of Skull Base, 342
14-6 Internal Aspects of Base of Skull:
Bones, 343
14-7 Internal Aspects of Base of Skull:
Orifices, 344
14-8 Skull Injuries, 345
14-9 Concussion, 346
14-10 Acute Epidural Hematoma, 347
14-11 Acute Subdural Hematoma, 348
14-12 CT Scans and MR Images of Intracranial
Hematomas, 349
14-13 Vascular Injury, 350
14-14 Initial Assessment and Management of
Head Injury, 351
14-15 Glasgow Coma Score, 352
14-16 Neurocritical Care and Management
after Traumatic Brain Injury: Devices
for Monitoring Intracranial
Pressure, 353
14-17 Neurocritical Care and Management:
Decompressive Craniectomy, 354